DOI: 10.1161/STROKEAHA.117.017460
,
,
PMID: 28455316
Issn Print: 0039-2499
Publication Date: 2017/06/01
Response by Bai et al to Letter Regarding Article, “Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis”
Ying Bai; Alena Shantsila; Gregory Y.H. Lip
Checking for direct PDF access through Ovid |
Abstract
Abstract unavailable for this article.